Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)
CNY 6.43
(0.94%)
CNY 6.43
(0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.1 Billion | 5.59 Billion | 2.67 Billion | 1.35 Billion | 729.39 Million | 580.35 Million |
| Cost of Revenue | 442.1 Million | 1.71 Billion | 865.18 Million | 360.75 Million | 141.58 Million | 95.77 Million |
| Gross Profit | 662.35 Million | 3.88 Billion | 1.8 Billion | 993.74 Million | 587.8 Million | 484.57 Million |
| Operating Expenses | 631.43 Million | 1.1 Billion | 701.13 Million | 518.09 Million | 437.44 Million | 367.43 Million |
| Selling, General and Administrative Expenses | 446.45 Million | 603.44 Million | 471.49 Million | 380.43 Million | 316.87 Million | 267.97 Million |
| Research and Development Expenses | 117.51 Million | 247.28 Million | 115.29 Million | 71.62 Million | 57.44 Million | 45.95 Million |
| Other Expenses | - | 256.63 Million | 114.34 Million | 66.03 Million | 63.12 Million | -75.5 Thousand |
| Cost and Expenses | 1.06 Billion | 2.82 Billion | 1.56 Billion | 878.84 Million | 579.03 Million | 463.21 Million |
| Operating Income | 42.59 Million | 2.19 Billion | 1.07 Billion | 468.83 Million | 156.25 Million | 126.01 Million |
| Interest Expense | 6.09 Million | 8.18 Million | 7.4 Million | 800.56 Thousand | 12.87 Thousand | 367.87 Thousand |
| Income Tax Expense | -31.69 Million | 326.46 Million | 172.24 Million | 69.31 Million | 17.56 Million | 19.19 Million |
| Earnings before Tax | 37.65 Million | 2.12 Billion | 1.05 Billion | 463.97 Million | 154.52 Million | 125.93 Million |
| Net Income | 140.47 Million | 1.72 Billion | 852.16 Million | 362.66 Million | 147.29 Million | 114.07 Million |
| Earnings Per Share Basic | 0.25 | 2.65 | 1.30 | 0.59 | 0.25 | 0.19 |
| Earnings Per Share Diluted | 0.25 | 2.65 | 1.30 | 0.59 | 0.25 | 0.19 |
| Weighted Average Shares Outstanding | 561.88 Million | 651.68 Million | 655.3 Million | 613.52 Million | 592.46 Million | 593.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 561.88 Million | 651.68 Million | 655.3 Million | 613.52 Million | 592.46 Million | 606.05 Million |
| Gross Margin | 0.60 | 0.69 | 0.68 | 0.73 | 0.81 | 0.83 |
| EBIT Margin | 0.21 | 0.52 | 0.45 | 0.39 | 0.27 | 0.28 |
| Profit Margin | 0.13 | 0.31 | 0.32 | 0.27 | 0.20 | 0.20 |
| EBITDA | 236.08 Million | 2.33 Billion | 1.15 Billion | 514.81 Million | 195.74 Million | 166.73 Million |
| Earnings Before Tax Margin | 0.04 | 0.39 | 0.40 | 0.35 | 0.21 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 197.61 Million | 225.78 Million | 181.3 Million | 1.09 Billion | 250.18 Million | 243.99 Million |
| Cost of Revenue | 92.29 Million | 98.55 Million | 90.99 Million | 521.74 Million | 126.75 Million | 114.71 Million |
| Gross Profit | 105.31 Million | 127.22 Million | 90.31 Million | 572.38 Million | 123.42 Million | 129.27 Million |
| Operating Expenses | 451.38 Million | 148.3 Million | 123.16 Million | 575.6 Million | 230.01 Million | 147.77 Million |
| Selling, General and Administrative Expenses | 412.11 Million | 54.79 Million | 98.95 Million | - | 168.06 Million | 194.49 Million |
| Research and Development Expenses | 19.06 Million | 21.54 Million | 24.29 Million | - | 29.22 Million | 31.2 Million |
| Other Expenses | -20.2 Million | 413.34 Thousand | 81.17 Thousand | -11.64 Million | -32.71 Million | -2.64 Million |
| Cost and Expenses | 543.68 Million | 246.86 Million | 214.16 Million | 1.09 Billion | 356.77 Million | 262.48 Million |
| Operating Income | -346.06 Million | -99.81 Million | -32.85 Million | -3.22 Million | -106.59 Million | 2.75 Million |
| Interest Expense | 485.51 Thousand | 419.19 Thousand | 463.53 Thousand | 4.94 Million | 1.09 Million | 1.38 Million |
| Income Tax Expense | -56.19 Million | 2.15 Million | -5.7 Million | -31.69 Million | -36.25 Million | -27.2 Million |
| Earnings before Tax | -327.51 Million | -99.4 Million | -33.19 Million | 37.65 Million | -84.24 Million | 109.41 Thousand |
| Net Income | -184.99 Million | -62.57 Million | -14.35 Million | 140.47 Million | -31.63 Million | 49.26 Million |
| Earnings Per Share Basic | -0.29 | -0.10 | -0.02 | - | -0.05 | 0.08 |
| Earnings Per Share Diluted | -0.29 | -0.10 | -0.02 | - | -0.05 | 0.08 |
| Weighted Average Shares Outstanding | 641.4 Million | 641.4 Million | 642.05 Million | 561.88 Million | 646.5 Million | 646.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 641.4 Million | 641.4 Million | 642.05 Million | 561.88 Million | 646.5 Million | 646.5 Million |
| Gross Margin | 0.53 | 0.56 | 0.50 | 0.52 | 0.49 | 0.53 |
| EBIT Margin | -1.65 | -0.07 | -0.24 | - | -0.23 | -0.07 |
| Profit Margin | -0.94 | -0.28 | -0.08 | 0.13 | -0.13 | 0.20 |
| EBITDA | -327.03 Million | -14.8 Million | -43.32 Million | - | -57.73 Million | -17.11 Million |
| Earnings Before Tax Margin | -1.75 | -0.44 | -0.18 | -0.00 | -0.43 | 0.01 |
0A3O
000898
HTCMY
OFSS
9921
002342